Author/Creator: Wu, Zhuli - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Wu, Zhuli

1. A first-in-human, phase 1a dose-escalation study of the selective MEK1/2 inhibitor FCN-159 in patients with advanced NRAS-mutant melanoma. (November 2022)

Authors:: Mao, Lili; Guo, Jun; Zhu, Lingjun; Jiang, Yu; Yan, Wangjun; Zhang, Jian; Hui, Ai-Min; Yang, Yuchen; Diao, Lei; Tan, Yan; Zhao, Han; Jiang, Yiqian; Wu, Zhuli; Si, Lu
Journal:: European journal of cancer
Issue:: Volume 175(2022)
Page Start:: 125
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase I study of FCN-411, a pan-HER inhibitor, in EGFR-mutated advanced NSCLC after progression on EGFR tyrosine kinase inhibitors. (April 2022)

Authors:: Lin, Lin; Pan, Hongming; Li, Xingya; Zhao, Chengling; Sun, Jiangtao; Hu, Xingsheng; Zhang, Yiping; Wang, Mengzhao; Ren, Xiubao; Luo, Xiaoyong; Shan, Guoyong; Hui, Ai-Min; Wu, Zhuli; Liu, Huilong; Tian, Ling; Shi, Yuankai
Journal:: Lung cancer
Issue:: Volume 166(2022)
Page Start:: 98
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Pulsed infrared stimulation evoked electrical potential in mouse vestibular system. (1st April 2022)

Authors:: Jiang, Weitao; Wang, Zihan; Xiao, Shijie; Zeng, Dingxuan; Wu, Zhuli; Peng, Cheng; Chen, Fangyi
Journal:: Neuroscience letters
Issue:: Volume 775(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗